|
1
|
Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj
A, Burnell M, Kalsi JK, Amso NN, Apostolidou S, Benjamin E,
Cruickshank D, et al: Ovarian cancer screening and mortality in the
UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A
randomised controlled trial. Lancet. 387:945–956. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Oza AM, Cibula D, Benzaquen AO, Poole C,
Mathijssen RH, Sonke GS, Colombo N, Špaček J, Vuylsteke P, Hirte H,
et al: Olaparib combined with chemotherapy for recurrent
platinum-sensitive ovarian cancer: A randomised phase 2 trial.
Lancet Oncol. 16:87–97. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hamanishi J, Mandai M, Ikeda T, Minami M,
Kawaguchi A, Murayama T, Kanai M, Mori Y, Matsumoto S, Chikuma S,
et al: Safety and antitumor activity of anti-PD-1 antibody,
nivolumab, in patients with platinum-resistant ovarian cancer. J
Clin Oncol. 33:4015–4022. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee
A, Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM,
et al EMBRACE; GEMO Study Collaborators; Breast Cancer Family
Registry; HEBON; KConFab Investigators; Australian Cancer Study
(Ovarian Cancer Investigators); Australian Ovarian Cancer Study
Group; Consortium of Investigators of Modifiers of BRCA1BRCA2, :
Identification of six new susceptibility loci for invasive
epithelial ovarian cancer. Nat Genet. 47:164–171. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Falconer H, Yin L, Grönberg H and Altman
D: Ovarian cancer risk after salpingectomy: A nationwide
population-based study. J Natl Cancer Inst. 107:4102015. View Article : Google Scholar
|
|
6
|
Bachmayr-Heyda A, Reiner AT, Auer K,
Sukhbaatar N, Aust S, Bachleitner-Hofmann T, Mesteri I, Grunt TW,
Zeillinger R and Pils D: Correlation of circular RNA abundance with
proliferation - exemplified with colorectal and ovarian cancer,
idiopathic lung fibrosis, and normal human tissues. Sci Rep.
5:80572015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim G, Ison G, McKee AE, Zhang H, Tang S,
Gwise T, Sridhara R, Lee E, Tzou A, Philip R, et al: FDA approval
summary: Olaparib monotherapy in patients with deleterious germline
BRCA-mutated advanced ovarian cancer treated with three or more
lines of chemotherapy. Clin Cancer Res. 21:4257–4261. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lauby-Secretan B, Scoccianti C, Loomis D,
Grosse Y, Bianchini F and Straif K; International Agency for
Research on Cancer handbook working group, : Body fatness and
cancer - viewpoint of the IARC working group. N Engl J Med.
375:794–798. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu Y, Day FR, Gustafsson S, Buchkovich ML,
Na J, Bataille V, Cousminer DL, Dastani Z, Drong AW, Esko T, et al:
New loci for body fat percentage reveal link between adiposity and
cardiometabolic disease risk. Nat Commun. 7:104952016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rebbeck TR, Mitra N, Wan F, Sinilnikova
OM, Healey S, McGuffog L, Mazoyer S, Chenevix-Trench G, Easton DF,
Antoniou AC, et al CIMBA Consortium, : Association of type and
location of BRCA1 and BRCA2 mutations with risk of breast and
ovarian cancer. JAMA. 313:1347–1361. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Walker JL, Powell CB, Chen LM, Carter J,
Bae Jump VL, Parker LP, Borowsky ME and Gibb RK: Society of
Gynecologic Oncology recommendations for the prevention of ovarian
cancer. Cancer. 121:2108–2120. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang F, Zhou J, Xie X, Hu J, Chen L, Hu Q,
Guo H and Yu C: Involvement of SRPK1 in cisplatin resistance
related to long non-coding RNA UCA1 in human ovarian cancer cells.
Neoplasma. 62:432–438. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hareyama H, Hada K, Goto K, Watanabe S,
Hakoyama M, Oku K, Hayakashi Y, Hirayama E and Okuyama K:
Prevalence, classification, and risk factors for postoperative
lower extremity lymphedema in women with gynecologic malignancies:
A retrospective study. Int J Gynecol Cancer. 25:751–757. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
McDermott FD, Heeney A, Kelly ME, Steele
RJ, Carlson GL and Winter DC: Systematic review of preoperative,
intraoperative and postoperative risk factors for colorectal
anastomotic leaks. Br J Surg. 102:462–479. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang WW, Liu KJ, Hu GL and Liang WJ:
Preoperative platelet/lymphocyte ratio is a superior prognostic
factor compared to other systemic inflammatory response markers in
ovarian cancer patients. Tumour Biol. 36:8831–8837. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shungin D, Winkler TW, Croteau-Chonka DC,
Ferreira T, Locke AE, Mägi R, Strawbridge RJ, Pers TH, Fischer K,
Justice AE, et al ADIPOGen Consortium; CARDIOGRAMplusC4D
Consortium; CKDGen Consortium; GEFOS Consortium; GENIE Consortium;
GLGC; ICBP; International Endogene Consortium; LifeLines Cohort
Study; MAGIC Investigators; MuTHER Consortium; PAGE Consortium;
ReproGen Consortium, : New genetic loci link adipose and insulin
biology to body fat distribution. Nature. 518:187–196. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu H, Di J, Bao Y, Zhang P, Zhang L, Tu Y,
Han X and Jia W: Visceral fat area as a new predictor of short-term
diabetes remission after Roux-en-Y gastric bypass surgery in
Chinese patients with a body mass index less than 35
kg/m2. Surg Obes Relat Dis. 11:6–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Osborn DJ, Kaufman MR, Mock S, Guan MJ,
Dmochowski RR and Reynolds WS: Urinary retention rates after
intravesical onabotulinumtoxinA injection for idiopathic overactive
bladder in clinical practice and predictors of this outcome.
Neurourol Urodyn. 34:675–678. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schafer AL, Li X, Schwartz AV, Tufts LS,
Wheeler AL, Grunfeld C, Stewart L, Rogers SJ, Carter JT, Posselt
AM, et al: Changes in vertebral bone marrow fat and bone mass after
gastric bypass surgery: A pilot study. Bone. 74:140–145. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tremaroli V, Karlsson F, Werling M,
Ståhlman M, Kovatcheva-Datchary P, Olbers T, Fändriks L, le Roux
CW, Nielsen J and Bäckhed F: Roux-en-Y gastric bypass and vertical
banded gastroplasty induce long-term changes on the human gut
microbiome contributing to fat mass regulation. Cell Metab.
22:228–238. 2015. View Article : Google Scholar : PubMed/NCBI
|
